Novartis is closely monitoring the U.S. reciprocal tariff policy, which may impose 25% tariffs on pharmaceuticals. The company plans to expand in Japan with radiopharmaceutical production by 2026 and recently acquired Mariana Oncology for $1B to strengthen its oncology portfolio.
Swiss pharmaceutical giant Novartis is closely monitoring the potential impact of the United States’ proposed reciprocal tariff policy, which is expected to take shape in early April. Chief Executive Vas Narasimhan confirmed in Tokyo that the company is assessing the implications of the policy, particularly on pharmaceutical imports.
U.S. President Donald Trump recently suggested imposing a 25% tariff on imported pharmaceuticals as part of broader trade measures targeting various industries, including semiconductors and automobiles. The move is part of efforts to restructure global trade dynamics and encourage domestic production.
Meanwhile, Novartis is expanding its footprint in Japan, with plans to commence mass production of radiopharmaceuticals in 2026. These precision cancer treatments offer targeted therapy, a growing focus for the pharmaceutical industry.
Last year, Novartis strengthened its oncology portfolio by acquiring U.S.-based Mariana Oncology for $1 billion upfront. This move enhances its offerings, which include prostate cancer treatment Pluvicto and Lutathera for rare gastrointestinal tumors.
As global trade policies evolve, Novartis continues to navigate regulatory challenges while advancing its commitment to innovative cancer therapies.
Read next
11:47
Japan has lost its decades long status as the global top creditor to Germany. A recent report suggests that a weakening yen, appreciating euro and American tariffs are responsible.
06:00
Five fishermen—three Peruvians and two Colombians—arrived safely in the Galapagos Islands on Saturday after spending 55 days adrift in the Pacific Ocean, according to the Ecuadorian navy.
14:20
World news
UN Secretary-General Antonio Guterres and Pakistan's Prime Minister Shehbaz Sharif engaged in their second call this week to discuss rising tensions in South Asia, stressing the need for restraint and diplomatic solutions.
10:53
Pyongyang returns
North Korea held its first Pyongyang International Marathon in six years, with foreign runners from China and Ethiopia. The event marked the country's gradual reopening post-pandemic, celebrating Kim Il Sung's birthday. The marathon symbolized North Korea's cautious return to normalcy.
What is your opinion on this topic?
Leave the first comment